Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

806 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Survival of patients with non-small cell lung cancer and brain metastases.
Mulvenna P, Barton R, Wilson P, Faivre-Finn C, Nankivell M, Stephens R, Langley R, Moore B, Ardron D. Mulvenna P, et al. Among authors: barton r. Clin Oncol (R Coll Radiol). 2011 Jun;23(5):375-6. doi: 10.1016/j.clon.2011.01.508. Epub 2011 Mar 9. Clin Oncol (R Coll Radiol). 2011. PMID: 21392952 No abstract available.
Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer?
Langley RE, Stephens RJ, Nankivell M, Pugh C, Moore B, Navani N, Wilson P, Faivre-Finn C, Barton R, Parmar MK, Mulvenna PM; QUARTZ Investigators. Langley RE, et al. Among authors: barton r. Clin Oncol (R Coll Radiol). 2013 Mar;25(3):e23-30. doi: 10.1016/j.clon.2012.11.002. Epub 2012 Dec 2. Clin Oncol (R Coll Radiol). 2013. PMID: 23211715 Clinical Trial.
Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial.
Mulvenna P, Nankivell M, Barton R, Faivre-Finn C, Wilson P, McColl E, Moore B, Brisbane I, Ardron D, Holt T, Morgan S, Lee C, Waite K, Bayman N, Pugh C, Sydes B, Stephens R, Parmar MK, Langley RE. Mulvenna P, et al. Among authors: barton r. Lancet. 2016 Oct 22;388(10055):2004-2014. doi: 10.1016/S0140-6736(16)30825-X. Epub 2016 Sep 4. Lancet. 2016. PMID: 27604504 Free PMC article. Clinical Trial.
Whole brain radiotherapy for non-small cell lung cancer - Authors' reply.
Langley RE, Nankivell M, Barton R, Faivre-Finn C, Mulvenna P; QUARTZ trial management group. Langley RE, et al. Among authors: barton r. Lancet. 2017 Apr 8;389(10077):1395-1396. doi: 10.1016/S0140-6736(17)30892-9. Lancet. 2017. PMID: 28402818 No abstract available.
Symptom response after palliative radiotherapy for patients with brain metastases.
Bezjak A, Adam J, Barton R, Panzarella T, Laperriere N, Wong CS, Mason W, Buckley C, Levin W, McLean M, Wu JS, Sia M, Kirkbride P. Bezjak A, et al. Among authors: barton r. Eur J Cancer. 2002 Mar;38(4):487-96. doi: 10.1016/s0959-8049(01)00150-2. Eur J Cancer. 2002. PMID: 11872340 Clinical Trial.
Radiotherapy for brain metastases: defining palliative response.
Bezjak A, Adam J, Panzarella T, Levin W, Barton R, Kirkbride P, McLean M, Mason W, Wong CS, Laperriere N. Bezjak A, et al. Among authors: barton r. Radiother Oncol. 2001 Oct;61(1):71-6. doi: 10.1016/s0167-8140(01)00426-1. Radiother Oncol. 2001. PMID: 11578731
806 results